Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland
Clostridium difficile A+B+ and A−B+ strains isolated from stool samples of patients with C. difficile-associated diarrhoea (CDAD) were selected from the University Hospital Warsaw collection. The binary-toxin genes cdtA and cdtB were detected by PCR in five of the 41 A+B+ strains tested, but in none of the 17 A−B+ strains tested, giving 8.6 % prevalence (5/58) of binary-toxin-positive strains. All of the strains that were positive for binary-toxin genes were grouped into toxinotype IV, suggesting that in this institution toxinotype IV might dominate among the population of C. difficile with binary-toxin genes.
AlfaM. J.,
KabaniA.,
LyerlyD. & 7 other authors; 2000; Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile -associated diarrhea. J Clin Microbiol 38:2706–2714
BarbutF.,
LalandeV.,
BurghofferB.,
ThienH. V.,
GrimprelE.,
PetitJ.-C.2002; Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40:2079–2083[CrossRef]
GericB.,
JohnsonS.,
GerdingD. N.,
GrabnarM.,
RupnikM.2003; Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41:5227–5232[CrossRef]
GericB.,
RupnikM.,
GerdingD. N.,
GrabnarM.,
JohnsonS.2004; Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53:887–894 5232
JohnsonS.,
KentS. A.,
O'LearyK. J.,
MerriganM. M.,
SambolS. P.,
PetersonL. R.,
GerdingD. N.2001; Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med 135:434–438[CrossRef]
KuijperE. J.,
de WeerdtJ.,
KatoH.,
KatoN.,
van DamA. P.,
van der VormE. R.,
WeelJ.,
van RheenenC.,
DankertJ.2001; Nosocomial outbreak of Clostridium difficile -associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20:528–534[CrossRef]
Meisel-MikołajczykF.,
LeszczyńskiP.,
van BelkumA.,
PituchH.,
Obuch-WoszczatyńskiP.,
RouyanG. H. S.1999; Enterotoxin-producing Bacteroides fragilis (ETBF) strains in stool samples submitted for testing of Clostridium difficile and its toxins. Anaerobe 5:217–219[CrossRef]
PituchH.,
van den BraakN.,
van LeeuwenW.,
van BelkumA.,
MartirosianG.,
Obuch-WoszczatyńskiP.,
ŁuczakM.,
Meisel-MikołajczykF.2001; Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-assoicated diarrhea in Poland. Clin Microbiol Infect 7:442–446[CrossRef]
PituchH.,
van BelkumA.,
van den BraakN.,
Obuch-WoszczatyńskiP.,
VerbrughH.,
Meisel-MikołajczykF.,
ŁuczakM.2003; Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C.difficile -associated diarrhea. J Clin Microbiol 41:4184–4187[CrossRef]
PopoffM. R.,
RubinE. J.,
GillD. M.,
BoquetP.1988; Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56:2299–2306
RupnikM.,
BraunV.,
SoehnF.,
JancM.,
HofstetterM.,
Laufenberg-FeldmannR.,
von Eichel-StreiberC.1997; Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile
. FEMS Microbiol Lett 148:197–202[CrossRef]
RupnikM.,
AvesaniV.,
JancM.,
von Eichel-StreiberC.,
DelméeM.1998; A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247
RupnikM.,
BrazierJ.,
DuerdenB.,
GrabnarM.,
StubbsS.2001; Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147:439–447
SambolS. P.,
MerriganM. M.,
LyerlyD.,
GerdingD. N.,
JohnsonS.2000; Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 68:5480–5487[CrossRef]
SpigagliaP.,
MastrantonioP.2002; Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40:3470–3475[CrossRef]
StubbsS. L.,
BrazierJ. S.,
O'NeillG. L.,
DuerdenB. I.1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463
StubbsS. L.,
RupnikM.,
GibertM.,
BrazierJ. S.,
DuerdenB. I.,
PopoffM. R.2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
. FEMS Microbiol Lett 186:307–312[CrossRef]
von Eichel-StreiberC.,
Zec-PirnatI.,
GrabnarM.,
RupnikM.1999; A nonsense mutation abrogates production of a functional enterotoxin A in Clostridium difficile toxinotype VIII strains of serogroups F and X. FEMS Microbiol Lett 178:163–168[CrossRef]
Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland